Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Sep 27;91(20):9282–9286. doi: 10.1073/pnas.91.20.9282

CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes.

J C Chang 1, L R Smith 1, K J Froning 1, B J Schwabe 1, J A Laxer 1, L L Caralli 1, H H Kurland 1, M A Karasek 1, D I Wilkinson 1, D J Carlo 1, et al.
PMCID: PMC44796  PMID: 7937756

Abstract

Psoriasis is an inflammatory skin disorder characterized by epidermal keratinocyte hyperproliferation in association with a cellular infiltrate. There is evidence that activated T cells play a role in psoriatic plaque formation. We examined the T-cell receptor beta-chain variable gene segment (V beta) use of epidermal T cells in shave biopsies of psoriatic lesions. Our results show increased expression of V beta 3 and/or V beta 13.1 messages in the CD8+, but not CD4+, T cells in the lesions of a majority of patients studied. Sequence analysis of complementarity-determining region 3 (CDR3) of these two V beta genes from the skin demonstrated monoclonality or marked oligoclonality. A second biopsy from the same or different lesions, performed 3.5-8 months later in four patients, again revealed increased V beta 3 and/or V beta 13.1 expression and clonality. Moreover, in three of the four patients, the same V beta CDR3 rearrangement was found in both biopsies, although there was no V beta CDR3 homology between patients. In two patients in which V beta 3 and/or V beta 13.1 was not increased, an increase in V beta 17 gene use and clonality was found. The clonality of V beta sequence data indicates these cells are recruited and expanded in situ. The persistence of V beta 3-and/or V beta 13.1-bearing CD8+ T cells in lesions that did not undergo resolution suggests their role as effector cells rather than as regulatory cells.

Full text

PDF
9282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boitel B., Ermonval M., Panina-Bordignon P., Mariuzza R. A., Lanzavecchia A., Acuto O. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J Exp Med. 1992 Mar 1;175(3):765–777. doi: 10.1084/jem.175.3.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Breathnach S. M. The skin immune system and psoriasis. Clin Exp Immunol. 1993 Mar;91(3):343–345. doi: 10.1111/j.1365-2249.1993.tb05906.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Demidem A., Taylor J. R., Grammer S. F., Streilein J. W. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells. J Invest Dermatol. 1991 Sep;97(3):454–460. doi: 10.1111/1523-1747.ep12481465. [DOI] [PubMed] [Google Scholar]
  5. DerSimonian H., Sugita M., Glass D. N., Maier A. L., Weinblatt M. E., Rème T., Brenner M. B. Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med. 1993 Jun 1;177(6):1623–1631. doi: 10.1084/jem.177.6.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dunn D. A., Gadenne A. S., Simha S., Lerner E. A., Bigby M., Bleicher P. A. T-cell receptor V beta expression in normal human skin. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1267–1271. doi: 10.1073/pnas.90.4.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elder J. T., Nair R. P., Guo S. W., Henseler T., Christophers E., Voorhees J. J. The genetics of psoriasis. Arch Dermatol. 1994 Feb;130(2):216–224. [PubMed] [Google Scholar]
  8. Foster C. A., Yokozeki H., Rappersberger K., Koning F., Volc-Platzer B., Rieger A., Coligan J. E., Wolff K., Stingl G. Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med. 1990 Apr 1;171(4):997–1013. doi: 10.1084/jem.171.4.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Griffiths C. E., Voorhees J. J. Immunological mechanisms involved in psoriasis. Springer Semin Immunopathol. 1992;13(3-4):441–454. doi: 10.1007/BF00200540. [DOI] [PubMed] [Google Scholar]
  10. Hall B. L., Finn O. J. PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity. Biotechniques. 1992 Aug;13(2):248–257. [PubMed] [Google Scholar]
  11. Hingorani R., Choi I. H., Akolkar P., Gulwani-Akolkar B., Pergolizzi R., Silver J., Gregersen P. K. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol. 1993 Nov 15;151(10):5762–5769. [PubMed] [Google Scholar]
  12. Paukkonen K., Naukkarinen A., Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8 + T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res. 1992;284(7):375–379. doi: 10.1007/BF00372065. [DOI] [PubMed] [Google Scholar]
  13. Sasaki T., Ikezawa Z., Nakajima H. Treatment of severe psoriasis with low dose cyclosporin A and the effect on the helper-suppressor T cell ratio in peripheral blood. J Dermatol. 1988 Dec;15(6):480–486. doi: 10.1111/j.1346-8138.1988.tb01195.x. [DOI] [PubMed] [Google Scholar]
  14. Tiilikainen A., Lassus A., Karvonen J., Vartiainen P., Julin M. Psoriasis and HLA-Cw6. Br J Dermatol. 1980 Feb;102(2):179–184. doi: 10.1111/j.1365-2133.1980.tb05690.x. [DOI] [PubMed] [Google Scholar]
  15. Uyemura K., Pirmez C., Sieling P. A., Kiene K., Paes-Oliveira M., Modlin R. L. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J Immunol. 1993 Dec 15;151(12):7095–7104. [PubMed] [Google Scholar]
  16. Wong R. L., Winslow C. M., Cooper K. D. The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today. 1993 Feb;14(2):69–74. doi: 10.1016/0167-5699(93)90061-o. [DOI] [PubMed] [Google Scholar]
  17. Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES